Chargement en cours...
IEAC或CEAC预处理方案用于淋巴瘤自体造血干细胞移植的疗效与安全性比较
OBJECTIVE: To evaluate the efficacy and safety of IEAC (idarubici, etoposide, cytosine arabinoside, and cyclophosphamide) and CEAC (lomustine, etoposide, cytosine arabinoside, and cyclophosphamide) high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) in the tr...
Enregistré dans:
| Publié dans: | Nan Fang Yi Ke Da Xue Xue Bao |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
南方医科大学学报编辑部
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835682/ https://ncbi.nlm.nih.gov/pubmed/33380399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12122/j.issn.1673-4254.2020.12.10 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|